| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Department of Medicine, University
of Pittsburgh School of Medicine, Montefiore
Hospital, Pittsburgh, Pennsylvania
Gynecomastia and impotence have been described as side-effects of cimetidine therapy. It
has previously been shown that cimetidine
possesses antiandrogenic properties and
competes for dihydrotestosterone (DHT) binding to the cytosol and nuclear fractions of the
rat prostate. Because this interaction may be
relevant to the clinical findings in man, the authors analyzed the effects of cimetidine on androgen binding to the human prostate, testis,
and serum. Cimetidine competed for DHT
binding sites in the human prostate with a displacement curve parallel to that of nonlabeled
DHT, whereas no binding to the testis or serum
was apparent. Neither histamine nor the H1 antagonist diphenhydramine was capable of inhibiting androgen binding to the human prostate. Thus, androgen antagonism may be the
mechanism of the endocrine side-effects of
cimetidine in man.
Key words: cimetidine, androgen binding, prostate, testis
Submitted on October 30, 1979
Revised on December 28, 1979
Accepted on January 4, 1980
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |